Blue Water Vaccines, Inc.
BWV · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.00 | -1.50 | -3.89 |
| FCF Yield | -2,209.34% | -64.51% | -0.33% | -0.28% |
| EV / EBITDA | -0.16 | 0.91 | -181.64 | -386.12 |
| Quality | ||||
| ROIC | -286.99% | -59.63% | -236.24% | -33.71% |
| Gross Margin | 41.80% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.18 | 0.65 | 0.60 | 1.08 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | -100.00% |
| Free Cash Flow Growth | 0.00% | -325.59% | -17.47% | -109.97% |
| Safety | ||||
| Net Debt / EBITDA | -0.16 | 1.91 | 0.57 | 2.66 |
| Interest Coverage | 105.74 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 22.93 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -921.44 | 0.00 | 0.00 | 0.00 |